1. The effect of total glucoside of paeony on gut microbiota in NOD mice with Sjögren’s syndrome based on high-throughput sequencing of 16SrRNA gene
   Wen-Wen Lu et al, 2020, Chinese Medicine CrossRef
2. A Promising Mouse Model of Graves' Orbitopathy Induced by Adenovirus Expressing Thyrotropin Receptor A Subunit
   Meng Zhang et al, 2021, Thyroid CrossRef
3. Targets of total glucosides of paeony in the treatment of Sjogren syndrome: A network pharmacology study
   Lu Xiao et al, 2023, Journal of the Chinese Medical Association CrossRef
4. Clinical Efficacy and Safety of Total Glucosides of Paeony for Primary Sjögren’s Syndrome: A Systematic Review
   Liang Jin et al, 2017, Evidence-Based Complementary and Alternative Medicine CrossRef
5. Challenges in Treatment of Primary Sjögren’s Syndrome and Opportunities for Chinese Medicine
   Jia-qi Hou et al, 2020, Chinese Journal of Integrative Medicine CrossRef
6. The Future of Targeted Treatment of Primary Sjögren’s Syndrome: A Focus on Extra-Glandular Pathology
   Weizhen Zeng et al, 2022, International Journal of Molecular Sciences CrossRef
7. The involvement of T cell pathogenesis in thyroid-associated ophthalmopathy
   Yazhuo Huang et al, 2019, Eye CrossRef
8. The Effectiveness and Safety of Total Glucosides of Paeony in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis
   Zhe Feng et al, 2019, Frontiers in Pharmacology CrossRef
9. Modulation of Apoptosis by Cytotoxic Mediators and Cell-Survival Molecules in Sjögren’s Syndrome
   Hideki Nakamura et al, 2018, International Journal of Molecular Sciences CrossRef
10. Total Glycosides of Peony Protects Against Inflammatory Bowel Disease by Regulating IL-23/IL-17 Axis and Th17/Treg Balance
    Qinglin Li et al, 2019, The American Journal of Chinese Medicine CrossRef
11. The immunoregulatory effects of total glucosides of peony in autoimmune diseases
    Mengna Zhao et al, 2024, Journal of Leukocyte Biology CrossRef